Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series
暂无分享,去创建一个
M. Konopleva | K. Patel | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | C. Dinardo | N. Pemmaraju | N. Short | S. Loghavi | B. Thakral | G. Tang | M. Yilmaz | Ahmad S. Alotaibi | G. Issa